Prostate Cancer Coverage From Every Angle

Nicholas D. James, PhD, MBBS, on Prostate Cancer: STAMPEDE Trial Results and NCCN Guidelines

Posted: Tuesday, October 23, 2018

Nicholas D. James, PhD, MBBS, of University Hospitals Birmingham NHS Trust, discusses study findings on treating metastatic castration-sensitive prostate cancer, including results on radiotherapy and abiraterone and how they relate to NCCN recommendations.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.